IL17A and infection: Although a fraction of Tregs produced IL-17A on d1 and d2 after infection as shown previously [22], Tregs still increased IL-17A in effector cells, decreased fungal burden, and modulated immunopathology and weight loss in Treg recipients during OPC on d5 (data not shown, [22]).